Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Resveratrol exerts differential effects in vitro and in vivo against ovarian cancer cells.

Stakleff KS, Sloan T, Blanco D, Marcanthony S, Booth TD, Bishayee A.

Asian Pac J Cancer Prev. 2012;13(4):1333-40.

2.

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.

Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE.

Cancer Res. 2010 Nov 15;70(22):9003-11. doi: 10.1158/0008-5472.CAN-10-2364. Epub 2010 Oct 8.

3.

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K.

Cancer Res. 2010 Oct 1;70(19):7392-9. doi: 10.1158/0008-5472.CAN-10-2027. Epub 2010 Sep 14.

4.

Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.

Luther DJ, Ohanyan V, Shamhart PE, Hodnichak CM, Sisakian H, Booth TD, Meszaros JG, Bishayee A.

Invest New Drugs. 2011 Apr;29(2):380-91. doi: 10.1007/s10637-009-9332-7. Epub 2009 Oct 8.

PMID:
19812893
5.

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.

Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52.

6.

Resveratrol inhibition of Propionibacterium acnes.

Docherty JJ, McEwen HA, Sweet TJ, Bailey E, Booth TD.

J Antimicrob Chemother. 2007 Jun;59(6):1182-4. Epub 2007 Apr 21.

PMID:
17449884
7.

Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography.

Boocock DJ, Patel KR, Faust GE, Normolle DP, Marczylo TH, Crowell JA, Brenner DE, Booth TD, Gescher A, Steward WP.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):182-7. Epub 2006 Nov 9.

8.

Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice.

Horn TL, Cwik MJ, Morrissey RL, Kapetanovic I, Crowell JA, Booth TD, McCormick DL.

Food Chem Toxicol. 2007 Jan;45(1):55-63. Epub 2006 Aug 8.

9.

Resveratrol-associated renal toxicity.

Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS.

Toxicol Sci. 2004 Dec;82(2):614-9. Epub 2004 Aug 25.

PMID:
15329443
10.

Prediction of chiral chromatographic separations using combined multivariate regression and neural networks.

Booth TD, Azzaoui K, Wainer IW.

Anal Chem. 1997 Oct 1;69(19):3879-83. doi: 10.1021/ac9702150.

PMID:
21639207
11.

Supplemental Content

Loading ...
Support Center